Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients

The immuno-receptor Triggering Expressed on Myeloid cells-1 (TREM-1) is activated during bacterial infectious diseases, where it amplifies the inflammatory response. Small studies suggest that TREM-1 could be ...

Source: Intensive Care Medicine Experimental - August 14, 2023 Category: Surgery Authors: S ébastien Gibot, Thomas Lafon, Laurent Jacquin, Benjamin Lefevre, Antoine Kimmoun, Anne Guillaumot, Marie-Reine Losser, Marion Douplat, Laurent Argaud, Guillaume De Ciancio, Lucie Jolly, Nina Touly, Marc Derive, Catherine Malaplate, Amandine Luc, Cédri Tags: Research Articles Source Type: research